Erschienen in:
17.05.2020 | Original Article
Short and mid-term outcomes of multimodal treatment for locally-advanced non-small cell lung cancer in elderly patients
verfasst von:
Stefano Bongiolatti, Francesca Mazzoni, Alessandro Gonfiotti, Giulia Di Pierro, Alberto Salvicchi, Sara Borgianni, Katia Ferrari, Luca Voltolini
Erschienen in:
General Thoracic and Cardiovascular Surgery
|
Ausgabe 11/2020
Einloggen, um Zugang zu erhalten
Abstract
Objective
Multimodality treatments are effective for locally advanced non-small cell lung cancer (LA-NSCLC) showing benefits in overall (OS) and disease-free survival (DFS), but these options are frequently denied to elderly patients.
Methods
The objectives of this retrospective study were: to investigate mortality, morbidity and oncological outcomes of pulmonary resection after induction therapy (IT) for NSCLC in elderly patients. We divided the cohort into two: patients < 70 years (group A) and patients ≥70 years (group B). A multivariable logistic regression was built to identify factors associated with morbidity.
Results
77 patients underwent pulmonary resection after IT, 27 were aged ≥70 years. Type of chemotherapy, surgical procedures, pathological stages were comparable between the two groups, while the preoperative use of chemo-radiation therapy regimen was more frequent in group A (p = 0.027). In-hospital mortality was similar, while the percentage of patients with complications (38% vs 48.1%, p = 0.47) and the complication rate (50% vs 77%, p = 0.01) were higher in group B, but the severity of complications was comparable. The multivariable analysis did not identify any risk factors associated with morbidity. OS at 3 years and DFS at 2 years were not different (61% vs 48.5%, p = 0.64; 61.7% vs 44%, p = 0.393).
Conclusions
Lung resection for LA-NSCLC after IT can be performed safely in selected elderly patients with favourable postoperative and mid-term oncological results.